Publications in collaboration with researchers from Yale University (3)

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

2021

  1. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17

2016

  1. Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification

    JAMA Psychiatry, Vol. 73, Núm. 2, pp. 113-120